You're Eating Enough Molybdenum, Yet Still Deficient. Here's Why.

Your VDR gene codes for the vitamin D receptor, a master regulator that sits on virtually every cell and controls how minerals (including molybdenum and other cofactors) are transported into the cell. When your VDR is functioning optimally, mineral absorption is efficient and coordinated.

VDR variants, carried by roughly 30 to 50% of the population depending on ancestry, reduce the sensitivity of this receptor. This means your cells respond weakly to vitamin D and other mineral-absorption signals. Even with adequate molybdenum in your diet, your cells may be pulling in only a fraction of what’s available.

You might notice you need higher doses of minerals to feel a benefit, that your levels never quite climb to the range you expect despite consistent supplementation, or that you experience multiple mineral deficiencies simultaneously even though you eat a varied diet.

The HFE gene is responsible for producing hepcidin, a hormone that tells your intestines how much iron to absorb. This system also has broad effects on how your body coordinates the absorption of other minerals, including molybdenum. When HFE is working correctly, your body absorbs just the right amount of iron and maintains balance across other mineral systems.

The H63D variant, present in roughly 15 to 20% of people with European ancestry, causes mild dysregulation of iron absorption. Your body may absorb too much or too little iron, creating downstream chaos in mineral homeostasis that affects molybdenum utilization. The C282Y variant causes severe iron overload and requires medical management.

You might experience unexplained anemia despite adequate iron intake, or you might struggle with iron overload. Either way, your molybdenum and other mineral systems suffer because the master regulator is out of tune.

TMPRSS6 encodes a protease that regulates hepcidin, fine-tuning how much iron your intestines absorb. Beyond iron, this gene influences the overall efficiency of your mineral-absorption machinery. When TMPRSS6 is functioning optimally, your body absorbs minerals proportionally to your needs.

The rs855791 variant, carried by approximately 45% of the population, is associated with lower iron absorption and lower ferritin levels. This variant makes your intestines more conservative about pulling in minerals, which may protect you from iron overload but also leaves you shortchanged for molybdenum and other essential elements.

You might notice that despite eating iron-rich foods or supplementing, your iron levels remain on the lower end. You feel fatigued, have poor exercise recovery, or struggle with brain fog. At the same time, your molybdenum status suffers because the same cautious absorption mechanism is limiting multiple minerals.

SLC30A8 encodes a zinc transporter that actively pumps zinc into cells, including pancreatic beta cells and cells throughout your digestive tract. Zinc is essential for enzyme function, immune health, and wound healing. Beyond its immediate roles, adequate zinc supports the overall efficiency of your mineral-absorption and detoxification systems.

The R325W variant (W allele), present in roughly 30% of the population, impairs the transporter’s ability to move zinc into cells. Your cells work harder to maintain adequate zinc, diverting energy and resources away from other mineral processes like molybdenum utilization.

You might feel that your immune system is sluggish, wounds heal slowly, or you struggle with skin health. You might also notice that despite eating enough zinc, you don’t feel the expected benefit from zinc supplementation. Your energy for detoxification and enzyme function suffers because zinc competition is draining your cellular resources.

MTHFR encodes an enzyme that converts dietary folate and B12 into their active forms, which power the methylation cycle. The methylation cycle is the foundation of hundreds of enzymatic reactions, including those required to activate and recycle molybdenum-dependent cofactors. When MTHFR is functioning optimally, you have abundant methyl groups to support detoxification, energy production, and mineral utilization.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70%. Your cells produce fewer methyl groups, which means molybdenum-dependent enzymes have less of the cofactors they need to function, even if molybdenum itself is present.

You might feel that you respond poorly to molybdenum supplementation alone. Brain fog persists. Detoxification feels sluggish. Joint pain doesn’t improve. That’s because the problem isn’t just molybdenum; it’s the broken methylation cycle that prevents molybdenum-dependent enzymes from working properly.

The COMT gene encodes an enzyme that breaks down catecholamines (dopamine, epinephrine, norepinephrine) and estrogen. COMT works closely with the methylation cycle; when it’s slow, it ties up methyl groups and slows down the entire methylation pathway. This has indirect but significant effects on molybdenum-dependent enzyme function because methylation drives the cofactor cycles these enzymes need.

COMT variants exist on a spectrum, but roughly 25 to 30% of the population carries the “slow” variant that reduces enzyme activity. Your body clears catecholamines slowly, which floods your system with stress metabolites and overwhelms the methylation cycle, leaving molybdenum enzymes starved for cofactors.

You might feel anxious, overstimulated by caffeine, or unable to manage stress. You might experience brain fog that worsens under pressure. Your molybdenum-dependent detoxification pathways become even more impaired because the methylation system is already stretched thin managing excess catecholamines.